In this section : Blood Transfusion
: Haematology and Thrombosis
Myeloma
Warfarin
Anticoagulation for AF, DVT and PE
Orthopaedic VTE Risk Assessment
Haemolytic Anaemia
Platelet Transfusion
Parenteral Iron in Adults >18 Years
Pulmonary Embolism
Deep Vein Thrombosis of Lower Extremities
Bleeding with Other Antithrombotics
Low Molecular Weight Heparin
Haematinic Testing
Thromboprophylaxis for Non-Covid Patients
Thrombophilia Screening
Antithrombotics in Hip Fracture
Reversal of Warfarin
Lumbar Puncture, Antiplatelet & Anticoagulant Drugs
Antithrombotics & Surgery
Iron Deficiency Anaemia
Unfractionated Heparin Infusion
Massive Pulmonary Embolism
Platelet Transfusion
Last updated 2nd December 2021
Introduction
- Platelets play a primary role in haemostasis i.e. the prevention of bleeding.
- The normal range for the platelet count in peripheral blood at all ages is 150 – 400 x109/L.
- This does not, however, tell you anything about platelet function and in certain circumstances platelets may be needed even though the count is normal.
What’s in a Bag of Platelets
- Pooled platelets are harvested by centrifuging whole blood from several donors
- Apheresis platelets are collected from a single donor
- One pack (apheresis or pooled) is termed one Adult Therapeutic Dose (ATD)
- One ATD should increase the platelet count by at least 20×109/L. This can be checked 10 minutes after the transfusion has completed
- If the increase is persistently below 20×109/L this may suggest refractoriness.
- All blood services in the UK screen for bacterial contamination routinely.
- Platelets expire 7 days after pooling
Indications for Platelet Transfusion
- Most platelets are given to prevent rather than to treat bleeding when the platelet count is less than or equal to 10×109 or between 10 and 20×109/L if there are additional risk factors for bleeding.
- Absolute thrombocytopenia, in the absence of any abnormality, is unlikely to be complicated by serious spontaneous haemorrhage if the count remains above 5×109/L.
- Platelets are given to prevent bleeding (prophylactic) in the following clinical situations:
- Reversible bone marrow failure including allogeneic stem cell transplant and critical illness
- Chronic bone marrow failure if patient is receiving intensive treatment or to prevent persistent bleeding
- Prophylactic platelet transfusions may not be required if patient is well and is having an autologous stem cell transplant.
- Prophylactic platelet transfusions are not required if patient has chronic bone marrow failure and is stable and well.
- Platelet transfusions are also given to prevent bleeding prior to an invasive procedure.
- Platelet transfusions are given to treat bleeding when WHO bleeding grade is 2 or above:
- Grade 1 – no bleeding
- Grade 2 – petechiae
- Grade 3 – mild blood loss
- Grade 4 – gross blood loss
- Grade 5- debilitating blood loss
- Note that in some conditions platelets can be contra-indicated – see table below.
Prophylactic Platelet Transfusion – No Procedure | |
---|---|
Reversible Bone Marrow Failure (BMF) including allogeneic stem cell transplantation | 10x109/L |
Reversible BMF with autologous stem cell transplantation (consider no prophlaxis) | 10x109/L |
Critical illness | 10x109/L |
Chronic BMF receiving intensive therapy | 10x109/L |
Chronic BMF to prevent persistent bleeding of grade 2 | Count variable |
Chronic stable BMF, abnormal platelet function, platelet consumption/destruction (e.g. DIC, TTP) or immune thrombocytopenia (ITP, HIT, PTP) | Not indicated |
Presence of risk factors for bleeding (e.g. sepsis, antibiotic treatment, abnormalities of haemostasis) | 10-20x109/L |
Reversible/chronic bone marrow failure/critical care | 10-20x109/L |
Abnormal platelet function, platelet consumption/destruction, immune thrombocytopenia | Not indicated |
Platelet Transfusion – Pre Procedure | |
---|---|
Central venous catheter (CVC) excluding PICC line | 20x109/L |
Lumbar puncture | 40x109/L |
Percutaneous live biopsy | 50x109/L |
Major surgery | 50x109/L |
Epidural anaesthesia, insertion & removal | 80x109/L |
Neurosurgery or phthalmic surgery involving posterior segment of the eye | 100x109/L |
Bone marrow aspirate or trephine biopsies, PICC line insertion, traction removal of central venous catheters (CVCs), cataract surgery | Not indicated |
Therapeutic Use - Bleeding WHO Grade 2 or Above | |
---|---|
Severe bleeding | 50x109/L |
Multiple trauma, brain or eye injury, spontaneous intracerebral haemorrhage | 100x109/L |
Bleeding (WHO Grade 2) but not severe | 30x109/L |
Links
Summary of Guidelines for Use of Platelet Transfusions from BSH Guideline 2016 [pdf]